AKT3 and non-small cell lung carcinoma: Based on previous reports, AKT3 is thought to be involved in tumorigenesis of NSCLC (37–43), and from our computational data, we predicted AKT3 as a direct target of miR-320a binding through its 3′UTR, shown in Figure 6B.